Blog & Resources
Evidence-based education on psychedelic therapy and plant medicine
Psilocybin for PTSD: What Veterans and First Responders Need to Know
The VA is now funding psilocybin research for the first time. Veterans with treatment-resistant PTSD are showing encouraging results in early trials. Here's what the evidence actually shows, what's available now, and what's still years away.
Service Center vs Facilitator: Understanding Oregon's Psilocybin License System
Oregon's psilocybin licensing system has four distinct categories — and confusing them could mean booking with the wrong kind of provider. Here's exactly what each license type means.
How Much Does a Psilocybin Retreat Cost? Complete 2026 Price Guide
Psilocybin retreats range from under $1,000 to over $10,000 — a 10x spread that confuses almost everyone researching them. Here's what actually drives those price differences, and how to figure out what value you're really getting.
Oregon vs Colorado: Which State Is Better for Your First Psilocybin Retreat?
Oregon and Colorado are the only two US states with licensed psilocybin services right now. They look similar from the outside, but the differences in how each program works can meaningfully affect your experience and your decision.
Psilocybin Safety: Side Effects, Risks, and Who Should Not Use It
Psilocybin has one of the more favorable safety profiles of any psychoactive substance studied clinically — but "favorable" doesn't mean "without risk." Here's what current research shows about side effects, who should avoid it, and what genuine red flags look like.
Psilocybin Legal States 2026: Updated Map & State-by-State Guide
Psilocybin legalization is moving fast. Oregon and Colorado lead the way with regulated access, New Mexico's program launches by the end of 2026, and over two dozen states have active legislation in motion.
What to Expect at Your First Psychedelic Retreat: A Complete Guide
Going to your first psychedelic retreat can feel overwhelming. This guide walks through every stage — from your first inquiry call to integration weeks later — so you know exactly what to expect.
Ketamine vs Psilocybin Retreats: Which Is Right for You?
Both are reshaping mental health treatment, but they're not interchangeable. Here's how ketamine and psilocybin retreats actually differ — legally, experientially, and practically.
How to Prepare for a Psychedelic Retreat: A 4-Week Checklist
What you do in the four weeks before a psilocybin retreat shapes the experience itself — sometimes more than the session does. Here's a week-by-week breakdown of what actually matters, and what doesn't.
What Is Psychedelic Therapy? A Complete Evidence-Based Introduction
Psychedelic therapy is generating more attention than ever — but most coverage either oversells it or dismisses it entirely. Here's a clear, honest introduction to what it actually involves, what the evidence shows, and what's currently available in the United States.
Considering Ayahuasca? What Americans Need to Know Before Traveling
Ayahuasca is federally illegal in the US, leading many Americans to travel abroad for ceremonies. But the safety landscape outside the US looks very different from regulated psilocybin programs and the risks are real.
Can You Legally Travel With Psilocybin? US Interstate Laws Explained
Psilocybin is legal in Oregon and Colorado — but what happens when you try to bring it home? The answer is clearer than most articles let on, and it matters before you book your retreat.
Best Psilocybin Retreats in Oregon 2026: Complete Legal Guide
Oregon made history as the first US state to legalize supervised psilocybin services. Here's everything you need to know before booking a retreat — including how to verify a center is actually licensed.
Psilocybin and Antidepressants: What You Need to Know Before a Retreat
Mixing psilocybin with antidepressants is one of the most common — and most misunderstood — questions in psychedelic preparation. Here's what current research actually says, and why every licensed retreat screens for this before booking.
Microdosing Psilocybin: What Research Actually Shows in 2026
Microdosing has become wellness culture's biggest psychedelic story. But when researchers actually tested it in controlled studies, the results were not what most people expect. Here's what the evidence actually shows.
Psilocybin Integration: What Comes After the Retreat (And Why It Matters Most)
The session itself often gets all the attention, but the weeks and months after the retreat are where the actual change happens. Here's what integration really involves — and why most people underestimate it until it's too late.
Psilocybin for Depression: What the Clinical Research Actually Shows
Psilocybin has become the most-studied psychedelic for depression — with results from Johns Hopkins, Imperial College London, and phase 2 trials worth taking seriously. Here's an honest look at what the evidence actually supports, and what it doesn't.
Psilocybin for End-of-Life Anxiety: The Research and What It Means
Some of the most striking clinical research on psilocybin has involved people facing life-threatening illness. The findings are unusual in both their magnitude and what they suggest about how humans can relate to mortality.
Finding a Therapist Who Understands Psychedelic Integration
The integration work after a psilocybin retreat often benefits from professional support — but not every therapist is equipped to handle what surfaces. Here's how to find one who actually knows what they're doing in this space.
Group Sessions vs Individual: Which Psilocybin Format Is Right for You?
Most psilocybin retreats offer two fundamentally different formats: small group sessions or one-on-one work. The choice affects cost, attention, depth, and the experience itself in ways that aren't always obvious upfront.
Ibogaine Treatment for Addiction: What the Research Shows and Where It's Legal
Ibogaine is generating explosive interest as a treatment for opioid addiction and PTSD — search interest has grown 400% in the past year. But the substance carries a documented cardiac risk that makes the difference between a supervised clinical setting and an unregulated one potentially life-or-death.